Enrollment of Study Subjects Sample Clauses

Enrollment of Study Subjects. Reasonable endeavors shall be made to ensure at least Study Subjects are enrolled, meeting all Protocol eligibility requirements during the enrollment period communicated by SynteractHCR. Enrollment will be on a competitive basis with each site enrolling as many Study Subjects as quickly as possible. Healthcare 1.7 Zařazování studijních subjektů. Bude vyvinuto přiměřené úsilí za účelem zařazení alespoň studijních subjektů a dodržení všech protokolem stanovených požadavků na způsobilost v průběhu období zařazování oznámeného společností SynteractHCR. Zařazování bude probíhat kompetitivním způsobem a každé z center zařadí maximální možný počet studijních subjektů, Provider shall inform SynteractHCR of the status of enrollment of Study Subjects in compliance with instructions received from SynteractHCR or Sponsor and/or the requirements of the Protocol. SynteractHCR will notify the Healthcare Provider when enrollment for the Study is complete. No other Study Subjects may be enrolled in the Study after notification that enrollment is complete. The Healthcare Provider must receive permission in writing from SynteractHCR and/or Sponsor to randomize greater than eligible Study Subjects for the Study. It is anticipated that the first Study Subjects will be screened within days of the receipt of the Study Drug by the Healthcare Provider. All Study Subjects must be enrolled pursuant to Protocol eligibility criteria and within the enrollment period. Sponsor shall not be obligated to pay for additional Study Subjects who are enrolled in the Study without Sponsor’s and or SynteractHCR prior written approval. co nejrychleji to bude možné. Poskytovatel zdravotní péče bude společnost SynteractHCR informovat o stavu zařazování studijních subjektů v souladu s pokyny přijatými od společnosti SynteractHCR nebo zadavatele a/nebo požadavky protokolu. Společnost SynteractHCR bude poskytovatele zdravotní péče informovat o dokončení zařazování subjektů do studie. Po takovém oznámení již do studie nesmějí být zařazeny žádné další studijní subjekty. Poskytovatel zdravotní péče musí od společnosti SynteractHCR a/nebo zadavatele získat písemné povolení k randomizaci dalších způsobilých studijních subjektů nad rámec subjektů. Očekává se, že výběr prvních studijních subjektů bude proveden do dnů od přijetí hodnoceného léčivého přípravku poskytovatelem zdravotní péče. Všechny studijní subjekty musejí být zařazeny v souladu s kritérii způsobilosti stanovenými protokolem a během období zař...
Sample 1
AutoNDA by SimpleDocs
Enrollment of Study Subjects. University agrees to make all reasonable efforts to recruit the appropriate number of subjects for the Study in accordance with the timelines set forth in this Agreement. If this Study is a multi-center study, University acknowledges and agrees that (i) the Study is being conducted as part of a multi-center clinical trial, (ii) that the number of clinical trial sites will be decided solely by Company, (iii) that these sites may enroll subjects in mutual competition, and (iv) that Company reserves the right to end subject enrollment when the desired number of Study subjects for all clinical trial sites participating in that Study has been reached.
Sample 1
Enrollment of Study Subjects. Participating Institutions shall coordinate the enrollment of subjects as participants in the Study (“Study Subjects”) in accordance with the terms and conditions of the Protocol. 
Sample 1

Related to Enrollment of Study Subjects

  • Enrollment The School shall maintain accurate and complete enrollment data and daily records of student attendance.

  • Evaluation of Students A teacher shall maintain the right and responsibility to determine grades and other evaluation of students within the grading policies of the District based upon professional judgment of available criteria pertinent to any given subject area or activity for which the teacher is responsible. No grade or evaluation shall be changed without consultation with the teacher.

  • Initial Enrollment Upon retirement, each new retiree who is eligible to enroll in plans under the Health Benefits Program shall receive uninterrupted coverage under the plan in which he or she was enrolled as an active employee, provided the employee submits all necessary applications and other required documentation in a timely fashion.

  • Enrollment Process The Department may, at any time, revise the enrollment procedures. The Department will advise the Contractor of the anticipated changes in advance whenever possible. The Contractor shall have the opportunity to make comments and provide input on the changes. The Contractor will be bound by the changes in enrollment procedures.

  • Enrollment Requirements You must maintain with Blue Cross and Blue Shield a current and updated listing of covered employees. You will be responsible for all claims costs and expenses associated with failure to maintain an accurate and current listing with Blue Cross and Blue Shield, unless such claims costs and expenses are due to an error on Blue Cross and Blue Shield’s part. Eligibility of an Employee In order to maintain health care coverage with Blue Cross and Blue Shield, an employee must meet the written eligibility requirements (such as length of service, active employment and number of hours worked) you impose as long as they do not conflict with Blue Cross and Blue Shield’s eligibility requirements. An eligible employee as defined by Blue Cross and Blue Shield means: • A permanent full-time employee regularly working 30 hours or more each week at the employer’s usual place(s) of business and who is paid a salary or wage in accordance with state and federal wage requirements; or • A permanent part-time employee regularly working at least 20 hours but less than 30 hours each week at the employer’s usual place(s) of business and who is paid a salary or wage in accordance with state and federal wage requirements; or • A disabled permanent full-time or part-time employee who is actively working despite the disability (including one who is engaged in a trial work period) and a disabled employee who is not actively working but whom the employer treats as an employee; or • A former employee (or a former covered dependent of the employee of the group) who qualifies for continued group coverage under federal or state law, but only if the employer maintains Blue Cross and Blue Shield group coverage for permanent full-time employees as defined in (a) above; or • A retired employee of the employer. Enrollment of a Member Newly hired employees who are eligible for group benefits can enroll in the benefits plan according to your eligibility requirements for coverage, provided that your requirements comply with Blue Cross and Blue Shield’s eligibility and enrollment requirements. The effective date of an eligible employee’s (or his or her dependent’s) membership in the benefits plan may be the Member’s initial eligibility date or your subsequent anniversary/renewal date, as long as: (a) Blue Cross and Blue Shield receives your written notice no later than 30 days after the Member’s enrollment notification period applicable to membership modifications (as described in the Subscriber Certificate for your benefits plan); and (b) you pay the applicable premium charges.

  • Special Enrollment Under the circumstances described below, referred to as “qualifying events”, eligible employees and/or eligible dependents may request to enroll in the Plan outside of the initial and annual open enrollment periods, during a special enrollment period.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Disenrollment 2.3.2.1. The Contractor shall:

  • Re-Study If Re-Study of the Interconnection Facilities Study is required due to a higher queued project dropping out of the queue or a modification of a higher queued project pursuant to Section 4.4, Transmission Provider shall so notify Interconnection Customer in writing. Such Re-Study shall take no longer than sixty (60) Calendar Days from the date of notice. Any cost of Re-Study shall be borne by the Interconnection Customer being re-studied.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

Time is Money Join Law Insider Premium to draft better contracts faster.